Compounds > cyclohexanol
Page last updated: 2024-08-18

cyclohexanol and telaprevir

cyclohexanol has been researched along with telaprevir in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alves, K; Asmal, M; DeSouza, C; Di Bisceglie, AM; Gane, E; George, S; Jacobson, IM; Kauffman, R; Kieffer, T; Koziel, MJ; Nelson, D; Sulkowski, M; Zhang, EZ1
Ardzinski, A; Bartels, DJ; Davis, A; Dorrian, J; Jiang, M; Kieffer, TL; Nelson, M; Nicolas, O; Rao, BG; Rijnbrand, R; Spanks, J; Sullivan, JC; Tigges, A; Zhang, EZ1
Hodges, MR; Ottosen, S; Parsley, TB; Patick, AK; Raney, AK; van der Veer, E; van Doorn, LJ; Yang, L; Zeh, K1

Trials

3 trial(s) available for cyclohexanol and telaprevir

ArticleYear
VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection.
    European journal of gastroenterology & hepatology, 2014, Volume: 26, Issue:7

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Cyclohexanols; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thiophenes; Treatment Outcome; Viral Nonstructural Proteins; Young Adult

2014
Genotypic and phenotypic analyses of hepatitis C virus variants observed in clinical studies of VX-222, a nonnucleoside NS5B polymerase inhibitor.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9

    Topics: Amino Acid Sequence; Antiviral Agents; Base Sequence; Cyclohexanols; Drug Resistance, Viral; Genetic Variation; Genotype; Hepacivirus; Hepatitis C; Humans; Molecular Sequence Data; Mutation; Oligopeptides; Phenotype; Replicon; Thiophenes; Viral Nonstructural Proteins; Virus Replication

2014
In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1

    Topics: 5' Untranslated Regions; Antiviral Agents; Carbamates; Cyclohexanols; Drug Resistance, Viral; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Macrocyclic Compounds; MicroRNAs; Molecular Targeted Therapy; Mutation; Oligonucleotides; Oligopeptides; Pyrrolidines; Quinolines; Replicon; Thiazoles; Thiophenes; Valine

2015